Next Article in Journal
Chitosan Enhances the Anti-Biofilm Activity of Biodentine against an Interkingdom Biofilm Model
Previous Article in Journal
Photofungizides Based on Curcumin and Derivates Thereof against Candida albicans and Aspergillus niger
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antibiotics
Volume 10
Issue 11
10.3390/antibiotics10111316
antibiotics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antimicrobial Resistance and Molecular Epidemiological Characteristics of Methicillin-Resistant and Susceptible Staphylococcal Isolates from Oral Cavity of Dental Patients and Staff in Northern Japan

by
Mina Hirose
1,
Meiji Soe Aung
2,*,
Atsushi Fukuda
1,
Shoko Yahata
1,
Yusuke Fujita
1,
Masato Saitoh
1,
Yukito Hirose
3,
Noriko Urushibara
2 and
Nobumichi Kobayashi
2
1
Division of Pediatric Dentistry, Department of Oral Growth and Development, School of Dentistry, Health Sciences University of Hokkaido, Ishikari-Tobetsu 061-0293, Japan
2
Department of Hygiene, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan
3
Division of Fixed Prosthodontics and Oral Implantology, Department of Oral Rehabilitation, School of Dentistry, Health Sciences University of Hokkaido, Ishikari-Tobetsu 061-0293, Japan
*
Author to whom correspondence should be addressed.
Antibiotics 2021, 10(11), 1316; https://doi.org/10.3390/antibiotics10111316
Submission received: 30 September 2021 / Revised: 26 October 2021 / Accepted: 26 October 2021 / Published: 29 October 2021
Versions Notes

Abstract

:
The acquisition of drug resistance and virulence by staphylococcal species colonizing humans is a growing public health concern. The present study was conducted to investigate the prevalence, antimicrobial resistance and genetic characteristics of Staphylococcus isolates from the oral cavity and skin (hand) of systemically healthy subjects with dental disease and dental staff in northern Japan. Among a total of 133 subjects (91 patients and 42 staff), 87 coagulase-positive Staphylococcus (83 S. aureus/4 S. argenteus) and 162 coagulase-negative Staphylococcus (CoNS) isolates were recovered from 59 (44.4%) and 95 (71.4%) subjects, respectively. Three oral isolates were methicillin-resistant S. aureus (MRSA) (3.6%, 3/83) that were genotyped as ST8-SCCmec-IVl, ST4775(CC1)-SCCmec-IVa and ST6562(CC8)-SCCmec-IVa. Remarkably, the ST6562 isolate harbored PVL genes on ΦSa2usa and type I ACME (arginine catabolic mobile element). Four methicillin-susceptible isolates were identified as S. argenteus belonging to ST1223 and ST2250, which harbored enterotoxin genes egc-2 and sey, respectively. Among the fourteen CoNS species identified, methicillin-resistant (MR) isolates were detected in five species (11 isolates, 13.3% of CoNS), with S. saprophyticus and S. haemolyticus being the most common. ACME was prevalent in only S. epidermidis and S. capitis. These findings indicated the potential distribution of USA300 clone-like MRSA, toxigenic S. argenteus and MR-CoNS in the oral cavity of dental patients.

1. Introduction

Staphylococcus is well-known commensal bacteria in humans and most mammals and forms the normal flora of the skin and mucous membrane. This genus has been divided into coagulase-positive and -negative groups that include more than forty species [1]. Human-associated coagulase-positive Staphylococcus (CoPS) represents more pathogenic groups of Staphylococcus, comprising at least three species, among which S. aureus is the most common cause of a wide variety of diseases including skin and soft tissue infections, pneumonia, bacteremia, septic shock, food poisoning and toxic shock syndrome [2]. S. argenteus and S. schweitzeri, which were previously included in S. aureus, were reclassified as new species of CoPS in 2015 [3]. In particular, S. argenteus has been recognized as an emerging pathogen distributed to humans and animals that causes various diseases, such as S. aureus, and reported worldwide [4]. S. aureus and S. argenteus produce diverse virulence factors, such as exotoxins (enterotoxins, exfoliative toxins, etc.), exoenzymes and adhesins, a part of which are associated with various symptoms due to infections of these organisms [5,6]. While coagulase-negative Staphylococcus (CoNS) is regarded as a less virulent group, some CoNS species are common opportunistic pathogens that pose a significant health burden [2]. Nosocomial infections with some CoNS species become difficult to treat, due to the ability of biofilm to form on indwelling medical devices [7].
During the past two decades, the global spread of methicillin-resistant S. aureus (MRSA) in the community has also been noted as a cause of disease in immunocompetent individuals, while it had traditionally been confined to hospital settings [8]. Similarly, methicillin-resistant CoNS (MR-CoNS) has also been increasingly recognized as a nosocomial pathogen in many species [2]. In its chromosome, methicillin-resistant Staphylococcus carries the staphylococcal cassette chromosome mec (SCCmec), which contains mecA encoding penicillin-binding protein 2a with low affinity to beta-lactams. The SCCmec of MRSA has been classified into 14 genotypes (I-XIV) [9,10], among which types I, II, III, IV and V are commonly reported for healthcare-associated (HA)-MRSA or community-associated (CA)-MRSA. The acquisition of virulence factors in CA-MRSA, which may imply an increased virulence, is a potential concern for public health. For example, a CA-MRSA clone USA300 that has been predominant in the US, characteristically produces Panton Valentine leukocidine (PVL) associated with severe symptoms and has an arginine catabolic mobile element (ACME) in its genome that is implicated with an increased adaptability to human skin [8,11].
The colonization of S. aureus/MRSA on anterior nares is associated with the pathogenesis of their infections [12], increasing the risk of bloodstream infections and other infections resulting in an elevated medical burden [13,14]. Similarly, the carriage of CoNS in skin is implicated in surgical site infections [15,16], and the spread of MR- and multidrug resistant CoNS among healthy individuals has been described [17]. Thus, the colonization of Staphylococcus has been characterized mainly for bacterial strains residing in the nasal cavity and the skin, which are considered the primary ecological niche of this genus. Although 12–30% of individuals carry S. aureus in their nasal cavity persistently, 30% (range 16–70%) are intermittent carriers [18]. In contrast, colonization in the oral cavity is considered more persistent [19,20], and the reported carriage rate of S. aureus in the oral cavity is almost similar to or higher than those in nare in some studies [21,22]. Furthermore, colonizing S. aureus was only detected in the oral cavity in a substantial part (approximately 25%) of carriers [23,24]. Accordingly, the oral cavity/oro-pharynx has been noted and described as a more significant reservoir of staphylococci than anterior nares, for lower respiratory infections, cross-infection and dissemination to other body sites [20,25,26,27,28].
In our previous study, the prevalence of MRSA and MR-CoNS in the oral cavity of healthy children and their genetic traits were analyzed in Hokkaido, the northern main island of Japan [29]. As a result, 6.3 and 50% of colonizing S. aureus and S. epidermidis were identified as being MR, respectively, with MRSA belonging to five STs (ST1, ST5, ST8, ST89 and ST120). The present study was conducted to investigate the drug resistance and genetic characteristics of oral staphylococcal isolates from subjects of all age groups (systematically healthy subjects with dental disease and dental staff) and compared with isolates from the skin of the subjects’ hand, to understand the spread of bacterial strain within a subject. The results of this study provided different features in the prevalence of oral MR and methicillin-susceptible (MS) staphylococcus, with the first identification of USA300 clone-like MRSA and MS S. argenteus in an oral cavity.

2. Results

2.1. Prevalence of Staphylococcal Isolates from Study Subjects

During a 15-month period starting in December 2019, a total of 133 subjects participated in this study. They consisted of 91 systemically healthy dental patients (74 and 17 subjects with mild and severe dental disease, respectively) and 42 dental staff (35 dentists and 7 dental hygienists). The age range of participants was 0–93 years (median age: 46.5 years), and sex ratio was 0.99 (Table S1). Seventy percent of the patients with mild disease were children (0–18 years), while most of those with severe disease were adults. For a bacterial culture, a saliva and a skin swab on the hand (fingers and palm) were taken from all the subjects, and additionally, a swab of the oral disease site was collected from the patients with severe disease. During the study period, there were few or no participants from March to June 2020 because of the decrease in dental patients caused by the COVID-19 pandemic. However, in other periods, the monthly number of study subjects was almost constant.
Among the 133 subjects, two CoPS species, S. aureus and S. argenteus, were isolated from 63 (47.4%) and 3 (2.3%) subjects, respectively, while CoNS was isolated from 95 subjects (71.4%). The CoPS-positive rates were higher in the dental patient groups (overall rate: 47.3%, 43/91) than in the staff (38.1%) (statistically not significant; p = 0.32) (Table 1). From any sampling sites of all the subjects, a total of 83 S. aureus, 4 S. argenteus and 162 CoNS isolates were recovered. CoPS was more frequently isolated from the oral cavity (58 isolates) than the hand (29 isolates), though 87% of CoNS isolates (141/162) were derived from a skin swab of the hand. Three MRSA and 11 MR-CoNS isolates were identified, showing detection rates of 3.6 and 8.3% in S. aureus and CoNS, respectively. S. argenteus isolates were all mecA-negative. MRSA was only isolated from the oral cavity (staff and dental patients with mild disease), while most of MR-CoNS isolates were recovered from the hand of patients.

2.2. Genotypes, Antimicrobial Resistance, Virulence Factors and Resistance Genes in CoPS

Eighty-three S. aureus isolates were classified into 11 coagulase genotypes (coa-types) and 20 STs, with coaXa/ST15 being the most common (11 isolates), followed by coa-IIIa/ST8 and coa-VIc/ST97 (10 isolates each), and coa-IVa/ST30 and coa-Vb/ST188 (8 isolates each) (Table 2). Three MRSA isolates were genotyped as ST8-SCCmec IVl, ST4775-SCCmec IVa and ST6562(CC8)-SCCmec IVa. ST4775 and ST6562 are single locus variants of ST1 (allelic profile: 1-712-1-1-1-1-1) and ST8 (allelic profile: 3-3-1-1-4-739-3), belonging to clonal complex (CC) 1 and CC8, respectively. The ST6562 isolate belonged to spa type t1188 having a repeat profile (11-19-12-21-34-24-34-22-25) similar to that of t008 (11-19-12-21-17-34-24-34-22-25).
Among the 18 antimicrobials examined for S. aureus, the highest resistance rate was found against AMP (45.8%), followed by ERY (24.1%), and CLI (20.5%) (Table S2). All the ST30 isolates showed resistance to these three antimicrobials, harboring blaZ and erm(A) (Table 2, Table S2). A high resistance rate to AMP was observed for ST15, ST20 and ST121, among which ST15 and ST121 included GEN-resistant isolates harboring aac(6′)-Ie-aph(2”)-Ia. Three MRSA isolates showed multidrug resistance having any of the aminoglycoside modifying enzyme genes and macrolide resistance genes. The ST6562 isolate had blaZ, aph(3′)-IIIa and msr(A). All the isolates are sensitive to LZD with MIC ranging between 0 and 2 μg/mL and none of the isolates harbored optrA, fexA and cfr genes.
The prevalence of virulence factors was analyzed in 38 S. aureus isolates with different genotypes and four S. argenteus isolates (Table S3). ST6562 (CC8) MRSA harbored PVL genes (lukS-PV-lukF-PV) located on a phage ΦSa2usa and had also type I ACME that included speG encoding spermine/spermidine N-acetyltransferase as typically seen in the USA300 clone [30], while ST8/SCCmec-IVl MRSA had tst-1, sec, sep and also spj encoding a cell wall-anchored protein unique to SCCmec IVl [31]. An enterotoxin gene cluster (egc: egc-1, seg-sei-sem-sen-seo; egc-2, seg-sei-sem-sen-seo-seu) was identified in various genotypes of MSSA, including ST20, ST30 and ST121, among which ST30 isolates also harbored tst-1. Enterotoxin genes sea and seb were present in ST8 and ST12 MSSA isolates, respectively. Exfoliative toxin genes eta or etd were detected in MSSA isolates with ST26, ST121, ST291 and ST1607. A variant gene of the elastin-binding protein (ebpS-v) [32] was only identified in ST121 isolates.
Four S. argenteus isolates were genotyped as coa-XV/ST1223 (two isolates) and coa-XId/ST2250 (two isolates), which carried egc-2 and sey, respectively. These showed susceptibility to all of the 18 antimicrobials examined.
S. aureus or S. argenteus were recovered from both the oral cavity (saliva, disease site) and the hand of 19 subjects (Table 3). Among them, isolates from the two sites of the 13 subjects showed identical genotypes and other genetic traits, and resistance profiles. The presence of ST2250 S. argenteus in saliva and on the hand was confirmed in a patient (12 years, female) with mild dental disease. In a single subject (B20-H05) with mild dental disease, though the isolates from saliva and the hand belonged to the same genotype (coa-X/ST15), they showed different profiles of resistance and their responsible genes.

2.3. CoNS Species, Prevalence of MR-CoNS and Antimicrobial Resistance

A total of 162 CoNS isolates were differentiated into 14 species, with S. warneri and S. capitis being dominant (35.8 and 32.1%, respectively) and prevalent mainly on the hand (Table 4). These two species and four other common species, i.e., S. saprophyticus, S. epidermidis, S. caprae and S. haemolyticus, accounted for 90% of all the CoNS isolates. MR-CoNS was detected in 13.3% (11 isolates; two from the oral cavity, nine from the hand) of all the isolates in the five species, with S. saprophyticus and S. haemolyticus being the most common. The SCCmec of MR-CoNS was mostly non-typeable (Table S4). ACME was only detected in S. epidermidis and S. capitis, with detection rates of 66.7 and 50%, respectively. The highest resistance rate was observed against FOF (46.9%), followed by ERY (21%) and AMP (16.7%) (Table S5). FOF resistance was common in S. warneri, S. capitis, S. saprophyticus, S. haemolyticus and S. caprae. Resistance to GEN was found mostly in S. warneri, and LVX resistance was only detected in S. saprophyticus and S. haemolyticus. In MR-CoNS isolates, the macrolide resistance genes (erm(A), erm(B), erm(C), or msrA) were commonly detected, in addition to the most prevalent blaZ (Table S6).

3. Discussion

In the present study, we first revealed the prevalence and genotypes (coa-type, ST) of MRSA and MSSA from the oral cavity of dental patients, and also the spectrum of CoNS species with their resistance phenotype and determinants. The prevalence of S. aureus and MRSA in an oral cavity reported to date varies depending on the study design having different subjects [33]. In four studies on systemically healthy dental patients, the isolation rate of S. aureus ranged from 5.9 to 36.6%, while MRSA 0–8.6% [34,35,36,37]. For other study subjects, the rates of oral S. aureus were described as 38–40% in admitted patients [21,24], 35–48% in healthcare workers [24,38], 15–45% in healthy dental students [22,34] and 26–36% in healthy children [23,28,29]. A study in Ireland showed a lower rate of S. aureus isolation from patients than healthcare workers, while there was a slightly higher rate of MRSA in patients [24]. The oral carriage rates of MRSA in healthy subjects were 1.9% (dental students) [22] and 4.1% (healthcare workers) [38], with MRSA accounting for 9–21% of colonizing S. aureus. Among the S. aureus from oral specimens, approximately 10% of the isolates were identified as MRSA [26]. In our present study aimed at dental patients and staff, the overall isolation rate of S. aureus (44.4%) represented a high level compared with those reported for dental patients as well as healthy individuals as described above. However, MRSA was detected at a low rate among study subjects (2.3%, 3/133), which was similar to that in our previous study on healthy children (MRSA rate, 1.7%) [29]. Thus, it is suggested that the low prevalence of MRSA career (approx. 2%) has been persisting in our study site. In addition, though the isolation rates of S. aureus were slightly higher in the dental patients than the dental staff, this difference was not statistically significant, and MRSA was identified in both groups. Accordingly, it seems that S. aureus and MRSA may be distributed evenly to the oral cavity of the two groups of subjects.
Our present study revealed the clonal structure of S. aureus from the oral cavity and showed the broad genetic diversity of MSSA with common genotypes coa-IIIa (ST8), coa-IVa (ST30), coa-Vb (ST188), coa-VIc (ST97), coa-VIIa (ST12) and coa-Xa (ST15). Among them, ST8, ST30 and ST15 were considered to be persistently prevalent because they were also found in the oral cavity of healthy children in our previous study [29]. Furthermore, ST12, ST15, ST20, CC45, ST97 and CC398, which accounted for 51% (42/83) of all S. aureus isolates, have been described as common genotypes among livestock-associated MSSA/MRSA [39,40,41]. This finding suggests that in the present study population, an unexpectedly large part of the S. aureus isolates in the oral cavity were presumably transmitted from animals followed by colonization, due to their reduced pathogenicity to humans. Most of the MSSA isolates were generally susceptible to the antimicrobials tested and harbored less virulence factors, suggesting less pathogenic significance to humans. However, several clones, including ST8, ST12, ST30 and ST121, harbored sea, seb, egc, tst-1, eta or etd, which are related to pathogenicity in staphylococcal infections [5,6]. In addition, the concomitant distribution of the same S. aureus clones to the oral cavity and the hand was confirmed in approx. 70% of the subjects demonstrating S. aureus in both sites. These observations may indicate that the oral cavity has a potential role as a reservoir of S. aureus that mediates disease in humans, through transmission via oral droplet or the direct contact of body sites contaminated with this microorganism.
Among the clinical isolates of MRSA from healthcare and community settings in Hokkaido, Japan, coa-IIa (CC5) is predominant, and coa-IIIa (CC8) and coa-VIIa (CC1, CC59) are also commonly detected [42,43,44]. Unlike these dominant clones, three MRSA isolates in the present study (ST8-SCCmec IVl, ST4775-SCCmec IVa, ST6562-SCCmec IVa) had unique characteristics. ST4775, a single-locus variant of ST1, was reported previously in only an MRSA with an SCCmec IVa strain from a pet cat in Japan [45], suggesting its potential relation to the animal. The ST8-SCCmec IVl isolate, which was derived from a young dental patient (13y) in the present study, was PVL-negative and harbored sec, sep, tst-1 and spj, which was characteristic of the CA-MRSA/J clone that emerged in Japan in 2003 as a cause of skin infections among children [31]. Despite the low prevalence, this clone has been identified among the CA- and HA-MRSA isolated from all ages in the Japanese population, occasionally leading to severe diseases [42,43,44,46,47]. Moreover, this clone was demonstrated in the oral cavity of healthy children in our previous study [29]. Therefore, it is conceivable that CA-MRSA/J has been potentially spread among the community in our study site. The colonizing nature as well as the pathogenic traits of this clone are suggested to be ascribable to the unique adhesin, a cell wall-anchored surface protein (CWASP/J) encoded by spj carried within SCCmec IVl [31,48]. A remarkable finding in our present study was the identification of ST6562 SCCmec IVa MRSA harboring PVL genes in Φsa2usa and ACME-I, which are typical traits of the USA300 clone [30]. ST6562 is a novel ST representing a single locus variant of ST8, and this isolate has a spa type closely related to that of the ST8 USA300 clone. Accordingly, the ST6562 MRSA is considered to be a genetic variant that originated from the USA300 clone. As a dominant CA-MRSA in the US, the USA300 clone has been evidently recognized since 2000, followed by global dissemination [49,50]. In Japan, since the first detection of this clone in 2007 [51], a low prevalence of this clone (0.2–3.1%) has been reported in community and healthcare settings [42,43,52,53]. Nevertheless, an increasing trend was also noted [53], and 5.1% of the isolates from blood samples were identified as this clone in our recent study [44]. Therefore, associated with the persistent spread of the USA300 clone among the Japanese population, ST6562 is suggested to have emerged as a local variant. Although the nasal colonization of the USA300 clone was described as a risk of infection route [54,55], the oral carriage of this clone has been scarcely reported, while only a report showed its colonization on the throat [56]. Our finding may indicate that the oral cavity should also be considered as a reservoir of such virulent MRSA clones.
It was notable that two genotypes of S. argenteus (ST1223, ST2250) were identified firstly in the oral cavity, in three subjects, with one carrying the same clone on their hand, while the nasal colonization of S. argenteus was demonstrated in tropical regions [57,58]. Except in highly endemic regions (Australia, Southeast Asia, Amazon), the prevalence of S. argenteus is very low [4]. In northern Japan, we reported that the frequency of S. argenteus corresponded to 0.6–0.7% of the total number of S. aureus clinical isolates [6,59]. In contrast, the incidence of colonizing S. argenteus, i.e., 5% of subjects (3/59) and 4.6% of isolated CoPS (4/87), in the present study appear to be remarkably high, suggesting that S. argenteus is prone to be carried asymptomatically by humans. As shown in the present study, the ST1223 and ST2250 strains specifically possess egc and sey, respectively [6,59], and a food poisoning outbreak due to ST1223 strain harboring seb was reported [60]. More research is necessary to evaluate S. argenteus colonization as a potential risk of disease in humans.
In our study, CoNS isolates were more commonly recovered from the hand than the oral cavity, and the frequencies by species were different from those observed for clinical isolates, with S. epidemidis being the most common and including more MR strains than other species [1,61]. In a German study, the mecA-positive rate of CoNS from the nasal cavity was 7% [17], which is comparable to that in our study (8.3%), although the composition of the CoNS species was considerably different. Though our CoNS isolates from the oral cavity/hand showed a susceptibility to most antimicrobials, a relatively high resistance rate (46.9%) was noted against FOF (fosfomycin), especially in S. warneri and S. capitis, in contrast to the susceptibility in all the S. aureus isolates. FOF resistance in staphylococcus is mediated by either a defective transporter with mutation in the chromosomal genes or the plasmid-associated FOF-inactivating enzyme, FosB [62]. Moreover, diverse variants have been known for the fosB gene depending on the staphylococcal species [63]. The identification of the fosB in the two CoNS species with FOF resistance is necessary to define its origin. Among CoNS, ACME has been most commonly identified in S. epidermidis clinical isolates [61,64]. However, in our study, S. capitis showed a prevalence of ACME (50%) comparable to S. epidemidis (67%), suggesting its increased colonizing ability. Accordingly, the genetic and phenotypic traits of S. capitis should be carefully monitored.
In conclusion, we revealed the prevalence, antimicrobial resistance and genetic characteristics of Staphylococcus from the oral cavity of dental patients and staff in northern Japan. PVL-positive USA300 clone-like MRSA, ST1223 and ST2250 S. argenteus were first identified as orally colonizing isolates. The results from the present study underscored the importance of the oral cavity as reservoir of staphylococci with diverse genetic traits related to human disease.

4. Materials and Methods

4.1. Study Design

This was an observational, cross-sectional study conducted in dental hospitals affiliated with Health Sciences University of Hokkaido, Ishikari-Tobetsu town, in Hokkaido, which is the northern main island of Japan. Two samples (saliva and skin swab from hand) taken from individual participants (dental patients or staff) were cultured for isolation of staphylococcus. The grown bacterial colonies were analyzed genetically for species, genotypes, virulence factors and drug resistance genes, as well as antimicrobial susceptibility testing. Informed consent was obtained from all the participants as shown below, and the confidentiality of participants’ information was ensured throughout the study, as approved by the institutional review board.

4.2. Study Subjects and Isolation of Staphylococcus

During the period between December 2019 and February 2021, oral (saliva) and hand (skin swab) samples were collected from dental patients and staff in two dental treatment facilities who agreed to participate to this study. Saliva specimens were collected from the floor of the mouth by using a sterile cotton swab. For hand swab specimens, a sterile cotton swab moistened with normal saline was rubbed on palms and fingers. Dental disease site samples were taken by using a sterile cotton swab. All the swab samples were directly plated on CHROMagar Staph aureus (Kanto Chemical Industry Co., Ltd., Tokyo, Japan) and incubated at 37 °C for 48 h aerobically. Staphylococcus-like colonies were subculture on blood agar plates followed by incubation at 37 °C overnight aerobically. Identification of bacterial species was performed by analysis of partial 16Sr RNA gene sequencing of PCR products with primers 16Sr-1: GATGAACGCTGGCGGCGTGCCT and 16Sr-2: TGTTACGACTTCACCCCAATC designed in this study. Individual isolates were stored in cryovials (Microbank, Pro-Lab Diagnostics, Richmond Hill, ON, Canada) at −80 °C and recovered when they were analyzed.
DNA samples were extracted from cultured bacterial cells by the use of achromopeptidase (FUJIFILM Wako Pure Chemical Corp., Osaka, Japan) as described previously [65]. The PCR mixture contained 200 μM dNTP, 0.5 μM each primer, 1.25 U Ex Taq DNA polymerase (Takara Bio Inc., Shiga, Japan) and its buffer with Mg2+ (final conc. 2 mM), extracted bacterial DNA (approximately 2–3 ng), and sterile distilled water to a final volume of 25 μL. A PCR was performed on a thermal cycler (Gene Atlas, ASTEC, Fukuoka, Japan) with the following conditions: preheating at 94 ℃ for 2 min, 30 cycles of denaturation at 94 ℃ for 15 s, annealing at 55 ℃ for 15 s and extension at 72 ℃ for 15 s, and a final extension at 72 ℃ for 3 min. PCR amplicons were analyzed for their size using electrophoresis on a 2% agarose gel. Nucleotide sequence was determined using Sanger sequencing with the PCR products using the BigDye Terminator v3.1 Cycle Sequencing kit (Applied Biosystems, Foster City, CA, USA) on an automated DNA sequencer (ABI PRISM 3100, Applied Biosystems, Foster City, CA, USA).

4.3. Antimicrobial Susceptibility Testing

For all the isolates, minimal inhibitory concentrations (MICs) within limited ranges were measured using a broth microdilution test using Dry Plate Eiken DP32 (Eiken, Tokyo, Japan) for the following 18 antimicrobials: oxacillin (OXA), ampicillin (AMP), cefazolin (CFZ), cefmetazole (CMZ), flomoxef (FMX), imipenem (IPM), gentamicin (GEN), arbekacin (ABK), erythromycin (ERY), clindamycin (CLI), vancomycin (VAN), teicoplanin (TEC), linezolid (LZD), minocycline (MIN), fosfomycin (FOF), levofloxacin (LVX), cefoxitin (FOX) and trimethoprim/sulfamethoxazole (SXT). MICs of GEN, ciprofloxacin (CIP), tetracycline (TET), doxycycline (DOX) and lincomycin (LIN) were measured manually using a broth microdilution test for selected isolates.
Resistance was judged according to the break points mentioned in the Clinical Laboratory Standards Institute guidelines for most of the antimicrobials tested (CLSI). For antimicrobial drugs, whose breakpoints are not defined by CLSI guidelines, we employed the European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoint for FOF (32 μg/mL, Staphylococcus spp.), and a unique breakpoint for ABK (4 μg/mL, which is higher than the 2 μg/mL defined by the Japanese Society of Chemotherapy for a respiratory infection), and a breakpoint of FMX (16 μg/mL) defined by the Japanese Society of Chemotherapy for a urinary tract infection.

4.4. Genetic Typing

For all the isolates, the presence of nuc, mecA, PVL genes and ACME-associated arcA was confirmed by a multiplex PCR assay as described by Zhang et al. [66]. In addition, to discriminate species of non-S. aureus complex (S. argenteus, S. schweitzeri) from S. aureus, a PCR targeting the non-ribosomal peptide synthetase (NRPS) gene with the primers nrps-F and nrps-R was performed as described previously [67]. For all the methicillin resistant (mecA-positive) isolates, SCCmec type and subtype of SCCmec-IV were determined using a multiplex PCR using previously published primers and conditions [68,69]. Long-range-PCR (LR-PCR), as described previously, was applied for all the ACME arcA-positive strains to assign ACME type I, II, II’ [61]. Genotype of staphylocoagulase gene (coa) of S. aureus was determined by partial coa sequences (D1, D2 and the central regions) and analyzed for their highly similar coa sequence by a BLAST search (http://blast.ncbi.nlm.nih.gov/Blast.cgi, accessed on 30 April 2021) to assign coa-type. Accessory gene regulator (agr) group was assigned by the PCR with specific primers, as previously described [70]. Sequence type (ST) was determined according to the scheme of multilocus sequencing typing (MLST) [71] and sequence of protein A gene X-region (spa type) was determined using a PCR and direct sequencing [72], using Ridom SpaServer (http://spa.ridom.de/index.shtml, accessed on 30 April 2021) for some selected S.aureus isolates. PVL-encoding phages (Φ108, ΦPVL, ΦSa2958, ΦSa2MW, ΦSLT, ΦTCH60, ΦSa2usa and ΦSa119) for the PVL-positive isolates were determined using a multiplex or uniplex PCR as described previously [73].

4.5. Detection of Virulence Factors and Drug Resistance Genes

The presence of 28 staphylococcal enterotoxin (SE) (-like) genes (sea-see, seg-selu, selx, sey, selw, selz, sel26 and sel27), the TSST-1 gene (tst-1) and exfoliative toxin genes (eta, etb and etd), leukocidins (lukDE and lukM), haemolysins (hla, hlb, hld and hlg), adhesin genes (eno, cna, sdrC, sdrD, sdrE, fib, clfA, clfB, fnbA, fnbB, icaA, icaD, edinA, edinB, bap, spj), modulators of host defense (sak, chp and scn) and ACME-I component speG was analyzed using multiplex or uniplex PCRs as described previously [43,74]. Genes conferring resistance to penicillin (blaZ), macrolides-lincosamides-streptogramins (ermA, ermB, ermC, msrA, lnuA, lnuB), aminoglycosides (aac(6′)-Im, aac(6′)-Ie-aph(2”)-Ia, ant(3”)-Ia, ant(4′)-Ia, ant(6)-Ia, ant(9)-Ia, ant(9)-Ib, aph(2”)-Ib, aph(2”)-Ic, aph(2”)-Id and aph(3′)-IIIa), linezolid (optrA) and chloramphenicol (cfr) were detected using a uniplex or multiplex PCR using the primers previously reported [43,75]. A PCR was performed as described above (4.2), while the annealing temperature of a PCR was different depending on the target gene.

4.6. Statistical Analysis

Statistical analyses were performed using IBM SPSS Statistics ver.26. The chi-square test was used to analyze the differences in the prevalence of bacterial attribute information among identified STs. A p-value < 0.05 was considered statistically significant.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/antibiotics10111316/s1, Table S1: Subjects of this study (n = 133), Table S2: Antimicrobial resistance profile of MRSA/MSSA/S. argenteus isolates (n = 87), Table S3: Genotype, drug resistance profile/gene and virulence factor in S. aureus (MRSA/MSSA) and S. argenteus isolates (n = 42), Table S4: Identification of SCCmec and ACME among staphylococcal isolates, Table S5: Antimicrobial resistance profile of CoNS isolates, Table S6: Drug resistance profile/gene in MR-CoNS (n = 11).

Author Contributions

Conceptualization, M.H., M.S.A. and N.K.; methodology, M.H., M.S.A. and N.U.; investigation, M.H., M.S.A. and N.U.; resources, M.H., A.F., S.Y., Y.F., M.S. and Y.H.; writing—original draft preparation, M.H. and M.S.A.; writing—review and editing, N.K.; supervision, M.S.A. and N.K.; project administration, N.K.; funding acquisition, M.H., M.S.A. and N.K. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by JSPS (Japan Society for the Promotion of Science) KAKENHI Grant Number JP19K10450, JP20H03933 and JP21K10401.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the dental research ethics committee of the Health Sciences University of Hokkaido, Japan (No. 177).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study. In case dental patients were children, consent was received from their guardians.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Becker, K.; Heilmann, C.; Peters, G. Coagulase-negative staphylococci. Clin. Microbiol. Rev. 2014, 27, 870–926. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Crossley, K.B.; Jefferson, K.K.; Archer, G.L.; Fowler, V.G., Jr. (Eds.) Staphylococci in Human Disease, 2nd ed.; Wiley-Blackwell: Oxford, UK, 2009. [Google Scholar]
  3. Tong, S.Y.; Schaumburg, F.; Ellington, M.J.; Corander, J.; Pichon, B.; Leendertz, F.; Bentley, S.D.; Parkhill, J.; Holt, D.C.; Peters, G. Novel staphylococcal species that form part of a Staphylococcus aureus-related complex: The non-pigmented Staphylococcus argenteus sp. nov. and the nonhuman primate-associated Staphylococcus schweitzeri sp. nov. Int. J. Syst. Evol. Microbiol. 2015, 65, 15–22. [Google Scholar] [CrossRef] [PubMed]
  4. Becker, K.; Schaumburg, F.; Kearns, A.; Larsen, A.R.; Lindsay, J.A.; Skov, R.L.; Westh, H. Implications of identifying the recently defined members of the Staphylococcus aureus complex S. argenteus and S. schweitzeri: A position paper of members of the ESCMID Study Group for Staphylococci and Staphylococcal Diseases (ESGS). Clin. Microbiol. Infect. 2019, 25, 1064–1070. [Google Scholar] [CrossRef] [PubMed]
  5. Larkin, E.A.; Carman, R.J.; Krakauer, T.; Stiles, B.G. Staphylococcus aureus: The toxic presence of a pathogen extraordinaire. Curr. Med. Chem. 2009, 16, 4003–4019. [Google Scholar] [CrossRef] [Green Version]
  6. Aung, M.S.; Urushibara, N.; Kawaguchiya, M.; Hirose, M.; Ike, M.; Ito, M.; Kobayashi, N. Distribution of virulence factors and resistance determinants in three genotypes of Staphylococcus argenteus clinical isolates in Japan. Pathogens 2021, 10, 163. [Google Scholar] [CrossRef]
  7. Schilcher, K.; Horswill, A.R. Staphylococcal biofilm development: Structure, regulation, and treatment strategies. Microbiol. Mol. Biol. Rev. 2020, 84, e00026-19. [Google Scholar] [CrossRef]
  8. David, M.Z.; Daum, R.S. Community-associated methicillin-resistant Staphylococcus aureus: Epidemiology and clinical consequences of an emerging epidemic. Clin. Microbiol. Rev. 2010, 23, 616–687. [Google Scholar] [CrossRef] [Green Version]
  9. Lakhundi, S.; Zhang, K. Methicillin-Resistant Staphylococcus aureus: Molecular characterization, evolution, and epidemiology. Clin. Microbiol. Rev. 2018, 31, e00020-18. [Google Scholar] [CrossRef] [Green Version]
  10. Urushibara, N.; Aung, M.S.; Kawaguchiya, M.; Kobayashi, N. Novel staphylococcal cassette chromosome mec (SCCmec) type XIV (5A) and a truncated SCCmec element in SCC composite islands carrying speG in ST5 MRSA in Japan. J. Antimicrob. Chemother. 2020, 75, 46–50. [Google Scholar] [CrossRef]
  11. Diep, B.A.; Gill, S.R.; Chang, R.F.; Phan, T.H.; Chen, J.H.; Davidson, M.G.; Lin, F.; Lin, J.; Carleton, H.A.; Mongodin, E.F.; et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 2006, 367, 731–739. [Google Scholar] [CrossRef]
  12. Kluytmans, J.; van Belkum, A.; Verbrugh, H. Nasal carriage of Staphylococcus aureus: Epidemiology, underlying mechanisms, and associated risks. Clin. Microbiol. Rev. 1997, 10, 505–520. [Google Scholar] [CrossRef]
  13. Asundi, A.; Stanislawski, M.; Mehta, P.; Baron, A.E.; Mull, H.J.; Ho, P.M.; Zimetbaum, P.J.; Gupta, K.; Branch-Elliman, W. Real-world effectiveness of infection prevention interventions for reducing procedure-related cardiac device infections: Insights from the veterans affairs clinical assessment reporting and tracking program. Infect. Control Hosp. Epidemiol. 2019, 40, 855–862. [Google Scholar] [CrossRef]
  14. Marzec, N.S.; Bessesen, M.T. Risk and outcomes of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia among patients admitted with and without MRSA nares colonization. Am. J. Infect. Control 2016, 44, 405–408. [Google Scholar] [CrossRef] [PubMed]
  15. Saleh, K.; Sonesson, A.; Persson, B.; Riesbeck, K.; Schmidtchen, A. A descriptive study of bacterial load of full-thickness surgical wounds in dermatologic surgery. Dermatol. Surg. 2011, 37, 1014–1022. [Google Scholar] [CrossRef] [PubMed]
  16. Turtiainen, J.; Hakala, T.; Hakkarainen, T.; Karhukorpi, J. The impact of surgical wound bacterial colonization on the incidence of surgical site infection after lower limb vascular surgery: A prospective observational study. Eur. J. Vasc. Endovasc. Surg. 2014, 47, 411–417. [Google Scholar] [CrossRef] [Green Version]
  17. Marincola, G.; Liong, O.; Schoen, C.; Abouelfetouh, A.; Hamdy, A.; Wencker, F.D.R.; Marciniak, T.; Becker, K.; Köck, R.; Ziebuhr, W. Antimicrobial resistance profiles of coagulase-negative staphylococci in community-based healthy individuals in Germany. Front. Public Health 2021, 9, 684456. [Google Scholar] [CrossRef]
  18. Wertheim, H.F.; Melles, D.C.; Vos, M.C.; van Leeuwen, W.; van Belkum, A.; Verbrugh, H.A.; Nouwen, J.L. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect. Dis. 2005, 5, 751–762. [Google Scholar] [CrossRef]
  19. Percival, R.S.; Challacombe, S.J.; Marsh, P.D. Age-related microbiological changes in the salivary and plaque microflora of healthy adults. J. Med. Microbiol. 1991, 35, 5–11. [Google Scholar] [CrossRef] [Green Version]
  20. Williamson, D.A.; Ritchie, S.; Keren, B.; Harrington, M.; Thomas, M.G.; Upton, A.; Lennon, D.; Leversha, A. Persistence, discordance and diversity of Staphylococcus aureus nasal and oropharyngeal colonization in school-aged children. Pediatr. Infect. Dis. J. 2016, 35, 744–748. [Google Scholar] [CrossRef]
  21. Nilsson, P.; Ripa, T. Staphylococcus aureus throat colonization is more frequent than colonization in the anterior nares. J. Clin. Microbiol. 2006, 44, 3334–3339. [Google Scholar] [CrossRef] [Green Version]
  22. Petti, S.; Kakisina, N.; Volgenant, C.M.; Messano, G.A.; Barbato, E.; Passariello, C.; de Soet, J.J. Low methicillin-resistant Staphylococcus aureus carriage rate among Italian dental students. Am. J. Infect. Control 2015, 43, e89–e91. [Google Scholar] [CrossRef]
  23. Esposito, S.; Terranova, L.; Zampiero, A.; Ierardi, V.; Rios, W.P.; Pelucchi, C.; Principi, N. Oropharyngeal and nasal Staphylococcus aureus carriage by healthy children. BMC Infect. Dis. 2014, 14, 723. [Google Scholar] [CrossRef] [Green Version]
  24. Kearney, A.; Kinnevey, P.; Shore, A.; Earls, M.; Poovelikunnel, T.T.; Brennan, G.; Humphreys, H.; Coleman, D.C. The oral cavity revealed as a significant reservoir of Staphylococcus aureus in an acute hospital by extensive patient, healthcare worker and environmental sampling. J. Hosp. Infect. 2020, 105, 389–396. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Lam, O.L.; McGrath, C.; Bandara, H.M.; Li, L.S.; Samaranayake, L.P. Oral health promotion interventions on oral reservoirs of Staphylococcus aureus: A systematic review. Oral Dis. 2012, 18, 244–254. [Google Scholar] [CrossRef]
  26. McCormack, M.G.; Smith, A.J.; Akram, A.N.; Jackson, M.; Robertson, D.; Edwards, G. Staphylococcus aureus and the oral cavity: An overlooked source of carriage and infection? Am. J. Infect. Control 2015, 43, 35–37. [Google Scholar] [CrossRef]
  27. Uwemedimo, J.; Fitzgerald-Hughes, D.; Kinnevey, P.; Shore, A.; Coleman, D.; Humphreys, H.; Poovelikunnel, T.T. Screening the nose, throat and the naso-pharynx for methicillin-resistant Staphylococcus aureus: A pilot study. J. Infect. Prev. 2020, 21, 155–158. [Google Scholar] [CrossRef] [PubMed]
  28. Patil, A.K.; Namineni, S.; Cheruku, S.R.; Penmetsa, C.; Penmetcha, S.; Mallineni, S.K. Prevalence of community-cssociated methicillin-resistant Staphylococcus aureus in oral and nasal cavities of 4 to 13-year-old rural school children: A cross-sectional study. Contemp. Clin. Dent. 2019, 10, 99–104. [Google Scholar]
  29. Hirose, M.; Aung, M.S.; Fukuda, A.; Murata, Y.; Saitoh, M.; Kobayashi, N. Prevalence and genetic characteristics of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci isolated from oral cavity of healthy children in Japan. Microb. Drug Resist. 2019, 25, 400–407. [Google Scholar] [CrossRef]
  30. Diep, B.A.; Stone, G.G.; Basuino, L.; Graber, C.J.; Miller, A.; des Etages, S.A.; Jones, A.; Palazzolo-Balance, A.M.; Perdreau-Remington, F.; Sensabaugh, G.F.; et al. The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: Convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 2008, 197, 1523–1530. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  31. Iwao, Y.; Ishii, R.; Tomita, Y.; Shibuya, Y.; Takano, T.; Hung, W.C.; Higuchi, W.; Isobe, H.; Nishiyama, A.; Yano, M.; et al. The emerging ST8 methicillin-resistant Staphylococcus aureus clone in the community in Japan: Associated infections, genetic diversity, and comparative genomics. J. Infect. Chemother. 2012, 18, 228–240. [Google Scholar] [CrossRef]
  32. Aung, M.S.; Urushibara, N.; Kawaguchiya, M.; Aung, T.S.; Mya, S.; San, T.; Nwe, K.M.; Kobayashi, N. Virulence factors and genetic characteristics of methicillinresistant and -susceptible Staphylococcus aureus isolates in Myanmar. Microb. Drug Resist. 2011, 17, 525–535. [Google Scholar] [CrossRef] [Green Version]
  33. Donkor, E.S.; Kotey, F.C. Methicillin-Resistant Staphylococcus aureus in the oral cavity: Implications for antibiotic prophylaxis and surveillance. Infect. Dis. 2020, 13, 1178633720976581. [Google Scholar]
  34. Blomqvist, S.; Leonhardt, Å.; Arirachakaran, P.; Carlen, A.; Dahlén, G. Phenotype, genotype, and antibiotic susceptibility of Swedish and Thai oral isolates of Staphylococcus aureus. J. Oral Microbiol. 2015, 7, 26250. [Google Scholar] [CrossRef]
  35. Kim, G.Y.; Lee, C.H. Antimicrobial susceptibility and pathogenic genes of Staphylococcus aureus isolated from the oral cavity of patients with periodontitis. J. Periodontal Implant Sci. 2015, 45, 223–228. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Koukos, G.; Sakellari, D.; Arsenakis, M.; Tsalikis, L.; Slini, T.; Konstantinidis, A. Prevalence of Staphylococcus aureus and methicillin resistant Staphylococcus aureus (MRSA) in the oral cavity. Arch. Oral Biol. 2015, 60, 1410–1415. [Google Scholar] [CrossRef]
  37. Kwapisz, E.; Garbacz, K.; Kosecka-Strojek, M.; Schubert, J.; Bania, J.; Międzobrodzki, J. Presence of egc-positive major clones ST 45, 30 and 22 among methicillin-resistant and methicillin-susceptible oral Staphylococcus aureus strains. Sci. Rep. 2020, 10, 18889. [Google Scholar] [CrossRef]
  38. Palazzo, I.C.V.; Gir, E.; Pimenta, F.C.; de Carvalho, M.J.; da Silva Canini, S.R.M.; Cruz, E.D.; da Costa Darini, A.L. Does the oral cavity represent an important reservoir for MRSA in healthcare workers? J. Hosp. Infect. 2010, 76, 277–278. [Google Scholar] [CrossRef]
  39. Hata, E.; Katsuda, K.; Kobayashi, H.; Uchida, I.; Tanaka, K.; Eguchi, M. Genetic variation among Staphylococcus aureus strains from bovine milk and their relevance to methicillin-resistant isolates from humans. J. Clin. Microbiol. 2010, 48, 2130–2139. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  40. Saei, H.D.; Panahi, M. Genotyping and antimicrobial resistance of Staphylococcus aureus isolates from dairy ruminants: Differences in the distribution of clonal types between cattle and small ruminants. Arch. Microbiol. 2020, 202, 115–125. [Google Scholar] [CrossRef]
  41. Verkade, E.; Kluytmans, J. Livestock-associated Staphylococcus aureus CC398: Animal reservoirs and human infections. Infect. Genet. Evol. 2014, 21, 523–530. [Google Scholar] [CrossRef] [PubMed]
  42. Aung, M.S.; Kawaguchiya, M.; Urushibara, N.; Sumi, A.; Ito, M.; Kudo, K.; Morimoto, S.; Hosoya, S.; Kobayashi, N. Molecular characterization of methicillin-resistant Staphylococcus aureus from outpatients in northern Japan: Increasing tendency of ST5/ST764 MRSA-IIa with arginine catabolic mobile element. Microb. Drug Resist. 2017, 23, 616–625. [Google Scholar] [CrossRef] [PubMed]
  43. Aung, M.S.; Urushibara, N.; Kawaguchiya, M.; Sumi, A.; Shinagawa, M.; Takahashi, S.; Kobayashi, N. Clonal diversity and genetic characteristics of methicillin-resistant Staphylococcus aureus isolates from a tertiary care hospital in Japan. Microb. Drug Resist. 2019, 25, 1164–1175. [Google Scholar] [CrossRef] [PubMed]
  44. Aung, M.S.; Urushibara, N.; Kawaguchiya, M.; Hirose, M.; Ito, M.; Habadera, S.; Kobayashi, N. Clonal diversity of methicillin-resistant Staphylococcus aureus (MRSA) from bloodstream infections in northern Japan: Identification of spermidine N-acetyltransferase gene (speG) in staphylococcal cassette chromosomes (SCCs) associated with type II and IV SCCmec. J. Glob. Antimicrob. Resist. 2021, 24, 207–214. [Google Scholar]
  45. Taniguchi, Y.; Koide, S.; Maeyama, Y.; Tamai, K.; Hayashi, W.; Tanaka, H.; Iimura, M.; Suzuki, M.; Nagano, Y.; Arakawa, Y.; et al. Predominance of methicillin-resistant Staphylococcus aureus SCCmec type II-CC5 and SCCmec type IV-CC1/CC8 among companion animal clinical isolates in Japan: Findings from phylogenetic comparison with human clinical isolates. J. Glob. Antimicrob. Resist. 2020, 20, 253–259. [Google Scholar] [CrossRef] [PubMed]
  46. Ishitobi, N.; Wan, T.W.; Khokhlova, O.E.; Teng, L.J.; Yamamori, Y.; Yamamoto, T. Fatal case of ST8/SCCmecIVl community-associated methicillin-resistant Staphylococcus aureus infection in Japan. New Microbes New Infect. 2018, 26, 30–36. [Google Scholar] [CrossRef]
  47. Kitagawa, H.; Ohge, H.; Hisatsune, J.; Kajihara, T.; Katayama, K.; Takahashi, S.; Sueda, T.; Sugai, M. Prosthetic valve endocarditis caused by ST8 SCCmecIVl type community-associated methicillin-resistant Staphylococcus aureus. Intern. Med. 2019, 58, 743–747. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  48. Wan, T.W.; Teng, L.J.; Yamamoto, T. Structures of a highly variable cell-wall anchored protein-encoding the spj gene from ST8/SCCmecIVl community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA/J) isolated from 2003 onwards: An indicator of a strongly invasive pathotype. Microbiol. Immunol. 2019, 63, 186–193. [Google Scholar] [CrossRef]
  49. Carrel, M.; Perencevich, E.N.; David, M.Z. USA300 Methicillin-Resistant Staphylococcus aureus, United States, 2000–2013. Emerg. Infect. Dis. 2015, 21, 1973–1980. [Google Scholar] [CrossRef]
  50. Mediavilla, J.R.; Chen, L.; Mathema, B.; Kreiswirth, B.N. Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA). Curr. Opin. Microbiol. 2012, 15, 588–595. [Google Scholar] [CrossRef]
  51. Shibuya, Y.; Hara, M.; Higuchi, W.; Takano, T.; Iwao, Y.; Yamamoto, T. Emergence of the community-acquired methicillin-resistant Staphylococcus aureus USA300 clone in Japan. J. Infect. Chemother. 2008, 14, 439–441. [Google Scholar] [CrossRef] [PubMed]
  52. Kawaguchiya, M.; Urushibara, N.; Yamamoto, D.; Yamashita, T.; Shinagawa, M.; Watanabe, N.; Kobayashi, N. Characterization of PVL/ACME-positive methicillin-resistant Staphylococcus aureus (genotypes ST8-MRSA-IV and ST5-MRSA-II) isolated from a university hospital in Japan. Microb. Drug Resist. 2013, 19, 48–56. [Google Scholar] [CrossRef] [PubMed]
  53. Takadama, S.; Nakaminami, H.; Sato, A.; Shoshi, M.; Fujii, T.; Noguchi, N. Dissemination of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus USA300 clone in multiple hospitals in Tokyo, Japan. Clin. Microbiol. Infect. 2018, 24, 1211.e1–1211.e7. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Immergluck, L.C.; Jain, S.; Ray, S.M.; Mayberry, R.; Satola, S.; Parker, T.C.; Yuan, K.; Mohammed, A.; Jerris, R.C. Risk of skin and soft tissue infections among children found to be Staphylococcus aureus MRSA USA300 carriers. West. J. Emerg. Med. 2017, 18, 201–212. [Google Scholar] [CrossRef] [Green Version]
  55. Moriya, M.; Tsurukiri, J.; Nakaminami, H.; Yamanaka, H.; Kobayashi, T.; Tsubouchi, N.; Yokomori, R.; Takadama, S.; Noguchi, N.; Matsumoto, T.; et al. A risk as an infection route: Nasal colonization of methicillin-resistant Staphylococcus aureus USA300 clone among contact sport athletes in Japan. J. Infect. Chemother. 2020, 26, 862–864. [Google Scholar] [CrossRef] [PubMed]
  56. Read, T.D.; Petit, R.A., 3rd; Yin, Z.; Montgomery, T.; McNulty, M.C.; David, M.Z. USA300 Staphylococcus aureus persists on multiple body sites following an infection. BMC Microbiol. 2018, 18, 206. [Google Scholar] [CrossRef]
  57. Ruimy, R.; Angebault, C.; Djossou, F.; Dupont, C.; Epelboin, L.; Jarraud, S.; Lefevre, L.A.; Bes, M.; Lixandru, B.E.; Bertine, M.; et al. Are host genetics the predominant determinant of persistent nasal Staphylococcus aureus carriage in humans? J. Infect. Dis. 2010, 202, 924–934. [Google Scholar] [CrossRef] [Green Version]
  58. Aung, M.S.; San, T.; Aye, M.M.; Mya, S.; Maw, W.W.; Zan, K.N.; Htut, W.H.W.; Kawaguchiya, M.; Urushibara, N.; Kobayashi, N. Prevalence and genetic characteristics of Staphylococcus aureus and Staphylococcus argenteus isolates harboring Panton-Valentine Leukocidin, enterotoxins, and TSST-1 genes from food handlers in Myanmar. Toxins 2017, 9, 241. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  59. Aung, M.S.; Urushibara, N.; Kawaguchiya, M.; Sumi, A.; Takahashi, S.; Ike, M.; Ito, M.; Habadera, S.; Kobayashi, N. Molecular epidemiological characterization of Staphylococcus argenteus clinical isolates in Japan: Identification of three clones (ST1223, ST2198, and ST2550) and a novel staphylocoagulase Genotype XV. Microorganisms 2019, 7, 389. [Google Scholar] [CrossRef] [Green Version]
  60. Wakabayashi, Y.; Umeda, K.; Yonogi, S.; Nakamura, H.; Yamamoto, K.; Kumeda, Y.; Kawatsu, K. Staphylococcal food poisoning caused by Staphylococcus argenteus harboring staphylococcal enterotoxin genes. Int. J. Food Microbiol. 2018, 265, 23–29. [Google Scholar] [CrossRef] [PubMed]
  61. Onishi, M.; Urushibara, N.; Kawaguchiya, M.; Ghosh, S.; Shinagawa, M.; Watanabe, N.; Kobayashi, N. Prevalence and genetic diversity of arginine catabolic mobile element (ACME) in clinical isolates of coagulase-negative staphylococci: Identification of ACME type I variants in Staphylococcus epidermidis. Infect. Genet. Evol. 2013, 20, 381–388. [Google Scholar] [CrossRef]
  62. Lee, Y.C.; Chen, P.Y.; Wang, J.T.; Chang, S.C. Prevalence of fosfomycin resistance and gene mutations in clinical isolates of methicillin-resistant Staphylococcus aureus. Antimicrob. Resist. Infect. Control. 2020, 9, 135. [Google Scholar] [CrossRef] [PubMed]
  63. Song, Z.; Wang, X.; Zhou, X.; Jiang, S.; Li, Y.; Ahmad, O.; Qi, L.; Li, P.; Li, J. Taxonomic distribution of FosB in human-microbiota and activity comparison of fosfomycin resistance. Front. Microbiol. 2019, 10, 200. [Google Scholar] [CrossRef] [PubMed]
  64. Barbier, F.; Lebeaux, D.; Hernandez, D.; Delannoy, A.S.; Caro, V.; François, P.; Schrenzel, J.; Ruppé, E.; Gaillard, K.; Wolff, M.; et al. High prevalence of the arginine catabolic mobile element in carriage isolates of methicillin-resistant Staphylococcus epidermidis. J. Antimicrob. Chemother. 2011, 66, 29–36. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Kobayashi, N.; Wu, H.; Kojima, K.; Taniguchi, K.; Urasawa, S.; Uehara, N.; Omizu, Y.; Kishi, Y.; Yagihashi, A.; Kurokawa, I. Detection of mecA, femA, and femB genes in clinical strains of staphylococci using polymerase chain reaction. Epidemiol. Infect. 1994, 113, 259–266. [Google Scholar] [CrossRef] [Green Version]
  66. Zhang, K.; McClure, J.A.; Elsayed, S.; Louie, T.; Conly, J.M. Novel multiplex PCR assay for simultaneous identification of community-associated methicillin-resistant Staphylococcus aureus strains USA300 and USA400 and detection of mecA and panton-valentine leukocidin genes, with discrimination of Staphylococcus aureus from coagulase-negative staphylococci. J. Clin. Microbiol. 2018, 46, 1118–1122. [Google Scholar]
  67. Zhang, D.F.; Xu, X.; Song, Q.; Bai, Y.; Zhang, Y.; Song, M.; Shi, C.; Shi, X. Identification of Staphylococcus argenteus in Eastern China based on a nonribosomal peptide synthetase (NRPS) gene. Future Microbiol. 2016, 11, 1113–1121. [Google Scholar] [CrossRef] [PubMed]
  68. Kondo, Y.; Ito, T.; Ma, X.X.; Watanabe, S.; Kreiswirth, B.N.; Etienne, J.; Hiramatsu, K. Combination of multiplex PCRs for staphylococcal cassette chromosome mec type assignment: Rapid identification system for mec, ccr, and major differences in junkyard regions. Antimicrob. Agents Chemother. 2007, 51, 264–274. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  69. Milheiriço, C.; Oliveira, D.C.; de Lencastre, H. Multiplex PCR strategy for subtyping the staphylococcal cassette chromosome mec type IV in methicillin-resistant Staphylococcus aureus: ‘SCCmec IV multiplex’. J. Antimicrob. Chemother. 2007, 60, 42–48. [Google Scholar] [CrossRef] [Green Version]
  70. Strommenger, B.; Cuny, C.; Werner, G.; Witte, W. Obvious lack of association between dynamics of epidemic methicillin-resistant Staphylococcus aureus in central Europe and agr specificity groups. Eur. J. Clin. Microbiol. Infect. Dis. 2004, 23, 15–19. [Google Scholar]
  71. Enright, M.C.; Day, N.P.; Davies, C.E.; Peacock, S.J.; Spratt, B.G. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 2000, 38, 1008–1015. [Google Scholar] [CrossRef] [Green Version]
  72. Shopsin, B.; Gomez, M.; Montgomery, S.O.; Smith, D.H.; Waddington, M.; Dodge, D.E.; Bost, D.A.; Riehman, M.; Naidich, S.; Kreiswirth, B.N. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J. Clin. Microbiol. 1999, 37, 3556–3563. [Google Scholar] [CrossRef] [Green Version]
  73. Aung, M.S.; San, T.; Urushibara, N.; San, N.; Oo, W.M.; Soe, P.E.; Kyaw, Y.; Ko, P.M.; Thu, P.P.; Hlaing, M.S.; et al. Molecular characterization of methicillin-susceptible and -resistant Staphylococcus aureus harboring Panton-Valentine Leukocidin-encoding bacteriophages in a tertiary care hospital in Myanmar. Microb. Drug Resist. 2020, 26, 360–367. [Google Scholar] [CrossRef] [PubMed]
  74. Aung, M.S.; Urushibara, N.; Kawaguchiya, M.; Ito, M.; Habadera, S.; Kobayashi, N. Prevalence and genetic diversity of staphylococcal enterotoxin (-Like) genes sey, selw, selx, selz, sel26 and sel27 in community-acquired methicillin-resistant Staphylococcus aureus. Toxins 2020, 12, 347. [Google Scholar] [CrossRef] [PubMed]
  75. Roy, S.; Aung, M.S.; Paul, S.K.; Ahmed, S.; Haque, N.; Khan, E.R.; Barman, T.K.; Islam, A.; Abedin, S.; Sultana, C.; et al. Drug resistance determinants in clinical isolates of Enterococcus faecalis in Bangladesh: Identification of oxazolidinone resistance gene optrA in ST59 and ST902 lineages. Microorganisms 2020, 8, 1240. [Google Scholar] [CrossRef] [PubMed]
Table
Table 1. S. aureus, S. argenteus and CoNS isolates from study subjects (n = 133).
Table 1. S. aureus, S. argenteus and CoNS isolates from study subjects (n = 133).
Study SubjectsNumber of S. aureus/S. argenteus-Positive Subjects in Any Site (%)SiteNumber of Isolates [mecA-Positive]
S. aureusS. argenteusCoNS
staffs (n = 42)16 (38.1)oral cavity (saliva)14 [1] 6
hand (skin)10 37
Patients with mild dental disease (n = 74)34 (45.9)oral cavity (saliva)30 [2]35 [1]
hand (skin)13179 [7]
Patients with severe dental disease *1 (n = 17)9 (52.9)oral cavity (saliva)7 4 [1]
dental disease site4 6
hand (skin)5 25 [2]
total (n = 133)59 (44.4) 83 [3]4 [0]162 [11]
*1 Patients with dental diseases included subjects with periodontitis, implantitis, deep dental caries, abscess, fistula.
Table
Table 2. Prevalence of coa genotype, ST, drug resistance genes and antimicrobial resistance profiles of S. aureus (n = 83) and S. argenteus (n = 4) isolates.
Table 2. Prevalence of coa genotype, ST, drug resistance genes and antimicrobial resistance profiles of S. aureus (n = 83) and S. argenteus (n = 4) isolates.
S. aureus/
S. argenteus		Coa GenotypeNo. of Isolates in Coa-Type (%)ST (CC)No. of Isolates in STSCCmec type [MRSA]Antimicrobial Resistance Profile *2,3Drug Resistance Genes *4
S. aureus (n = 83)IIa ST5 (CC5)1 All susceptible
3 (3.6)ST261 AMPblaZ
ST1607 (CC97) 1 AMPblaZ
IIIa11 (13.3)ST8 (CC8)10SCCmec IVl (1 isolate)OXA (10%), FOX (10%), AMP (60%), ERY (20%) CLI-i (20%)blaZ (60%), erm(C) (10%), erm(A) (10%)
ST6562 *1 (CC8)1SCCmec IVaOXA, FOX, AMP, ERY, LVXblaZ, aph(3’)-IIIa, msrA
IVa8 (9.6)ST30 (CC30)8 AMP, ERY, CLI-i, GEN (12.5%)blaZ, erm(A), aac(6’)-Ie-aph(2’’)-Ia (12.5%)
Va6 (7.2)ST121 (CC121)6 AMP (66.7%), ERY (33.3%), CLI-i (33.3%), GEN (66.7%), LVX (16.7%)blaZ (66.7%), erm(C) (33.3%), aac(6’)-Ie-aph(2’’)-Ia (16.7%)
Vb8 (9.6)ST188 (CC1)8 LVX (25%)
VIc10 (12.0)ST97 (CC97)10 AMP (20%)blaZ (20%)
VIIa11 (13.3)ST12 (CC12)8 All susceptible
ST81 (CC1)2 AMP, ERY, CLI-iblaZ, erm(A)
ST4775 (CC1)1SCCmec IVaOXA, FOX, AMP, ERY, CLI-iblaZ, erm(A)
VIIb9 (10.8)ST45 (CC45)5 AMP (20%)blaZ (20%)
ST508 (CC45)2 All susceptible
ST291 (CC398)1 All susceptible
ST398 (CC398)1 ERY, CLI-ierm(C)
VIIIa4 (4.8)ST20 (CC20)4 AMPblaZ
Xa12 (14.5)ST15 (CC15)11 AMP (91%), GEN (36.7%)blaZ (91%), aac(6’)-Ie-aph(2’’)-Ia (36.7%)
ST7181 ERY, CLI-ierm(A)
XIc1 (1.2)ST109 (CC1)1 AMP, ERY, CLI-iblaZ, erm(A)
S. argenteus (n = 4)XId2 (50)ST2250 2 All susceptible
XV2 (50)ST1223 2 All susceptible
*1 Novel ST detected in this study. This isolate had PVL phage ΦSa2USA and ACME-I (USA300 related clone). *2 Abbreviations: ABK, arbekacin; AMP, ampicillin; CFZ, cefazolin; CLI, clindamycin; CMZ, cefmetazole; ERY, erythromycin; FMX, flomoxef; FOF, fosfomycin; FOX, cefoxitin; GEN, gentamicin; IPM, imipenem; LVX, levofloxacin; MIN, minocycline; OXA, oxacillin; SXT, sulfamethoxazole-trimethoprim; CLI-i, inducible resistance to clindamycin (confirmed by D-zone test). *3 When a resistance gene is not present in all isolates of the same ST, prevalence (%) is indicated in parentheses. None of the isolates showed resistance to ABK, CFZ, CMZ, FMX, IPM, MIN, FOF, SXT, LZD (linezolid), TEC (teicoplanin) and VAN (vancomycin).*4 The following genes were not detected in any isolates: erm(B), ant(6)-Ia, aac(6’)-Im, ant(9)-Ia, ant(9)-Ib, ant(3”)-Ia, aph(2”)-Ib, aph(2”)-Ic, aph(2”)-Id, optr-A, cfr and fexA.
Table
Table 3. Characteristics of S. aureus / S. argenteus isolated from both oral cavity and hand of subjects (n = 19).
Table 3. Characteristics of S. aureus / S. argenteus isolated from both oral cavity and hand of subjects (n = 19).
No.Age/SexIsolate IDSubject Category *1Site (Sample)S.aureus/S.argenteusCoa TypeST (CC)Antimicrobial Resistance ProfileDrug Resistance Genes
126/MA20-KT1saliva S.aureusVIIaST20 (CC20)AMPblaZ
handS.aureusVIIaST20 (CC20)AMPblaZ
225/MA20-IHB1saliva S.aureusVbST188 (CC1)All susceptible
handS.aureusVbST188 (CC1)All susceptible
325/MA20-EK1saliva S.aureusVaST121 (CC121)AMP, GENblaZ, aac(6’)-Ie-aph(2’’)-Ia
handS.aureusVaST121 (CC121)AMP, GENblaZ, aac(6’)-Ie-aph(2’’)-Ia
426/MB20-KF1salivaS.aureusVIIbST45 (CC45)AMPblaZ
saliva S.aureusIIIaST8 (CC8)AMPblaZ
handS.aureusXIcST109 (CC1)AMP, ERY, CLI-iblaZ, erm(A)
528/MB20-HS1saliva S.aureusIIIaST8 (CC8)All susceptible
handS.aureusIIIaST8 (CC8)All susceptible
629/MA21-OY1saliva S.aureusIIIaST8 (CC8)All susceptible
handS.aureusIIIaST8 (CC8)All susceptible
728/MA21-OYK1saliva S.aureusXaST15 (CC15)All susceptible
handS.aureusXaST15 (CC15)All susceptible
817/MA20-H102saliva S.aureusVIIaST12 (CC12)All susceptible
handS.aureusVIIaST12 (CC12)All susceptible
99/MA20-H162saliva S.aureusVIIaST12 (CC12)All susceptible
handS.aureusVIcST97 (CC97)All susceptible
108/MA20-H202saliva S.aureusVIIaST12 (CC12)All susceptible
handS.aureusVIIaST12 (CC12)All susceptible
1110FA20-H212saliva S.aureusVIIaST12 (CC12)All susceptible
handS.aureusVIcST97 (CC97)All susceptible
127/FA20-H222saliva S.aureusVIIaST12 (CC12)All susceptible
handS.aureusVIcST97 (CC97)All susceptible
138/MA20-H242saliva S.aureusVIcST97 (CC97)All susceptible
handS.aureusVIcST97 (CC97)All susceptible
149/FA20-H402saliva S.aureusVIIbST45 (CC45)All susceptible
handS.aureusVIIbST45 (CC45)All susceptible
1512/FA21-H092saliva S.argenteusXIdST2250All susceptible
handS.argenteusXIdST2250All susceptible
1610/FB20-H052saliva S.aureusXaST15 (CC15)AMPblaZ
handS.aureusXaST15 (CC15)AMP, GENblaZ, aac(6’)-Ie-aph(2’’)-Ia
1715/MA20-D33disease site S.aureusVIcST97 (CC97)AMPblaZ
handS.aureusVIcST97 (CC97)AMPblaZ
1810/FA20-D103saliva S.aureusVIIaST81 (CC1)AMP, ERY, CLI-iblaZ, erm(A)
handS.aureusVIIbST508 (CC45)All susceptible
1958/MA21-D043saliva S.aureusVIcST97 (CC97)All susceptible
handS.aureusVIcST97 (CC97)All susceptible
*1 1, hospital staff (n = 7); 2, patient with mild dental disease (n = 9); 3, patient with severe dental disease (n = 3).
Table
Table 4. Species of CoNS isolated from subjects.
Table 4. Species of CoNS isolated from subjects.
CoNS SpeciesNo. of Isolates [mecA-Positive]
Oral CavityHandDental Disease SiteTotal (n = 162) (%)
S. warneri651 [1]158 (35.8) [1]
S. capitis246452 (32.1)
S. saprophyticus2 [1]10 [4]012 (7.4) [5]
S. epidermidis4 [1]419 (5.6) [1]
S. caprae0808 (5.0)
S. haemolyticus07 [3]07 (4.3) [3]
S. cohnii0505 (3.1)
S. lugdunensis12 [1]03 (1.9) [1]
S. pasteuri0202 (1.2)
S. xylosus0202 (1.2)
S. auricularis0101 (0.6)
S. condimenti0101 (0.6)
S. hominis0101 (0.6)
S. petrasii0101 (0.6)
Total 15 [2]141 [9]6162 [11]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Hirose, M.; Aung, M.S.; Fukuda, A.; Yahata, S.; Fujita, Y.; Saitoh, M.; Hirose, Y.; Urushibara, N.; Kobayashi, N. Antimicrobial Resistance and Molecular Epidemiological Characteristics of Methicillin-Resistant and Susceptible Staphylococcal Isolates from Oral Cavity of Dental Patients and Staff in Northern Japan. Antibiotics 2021, 10, 1316. https://doi.org/10.3390/antibiotics10111316

AMA Style

Hirose M, Aung MS, Fukuda A, Yahata S, Fujita Y, Saitoh M, Hirose Y, Urushibara N, Kobayashi N. Antimicrobial Resistance and Molecular Epidemiological Characteristics of Methicillin-Resistant and Susceptible Staphylococcal Isolates from Oral Cavity of Dental Patients and Staff in Northern Japan. Antibiotics. 2021; 10(11):1316. https://doi.org/10.3390/antibiotics10111316

Chicago/Turabian Style

Hirose, Mina, Meiji Soe Aung, Atsushi Fukuda, Shoko Yahata, Yusuke Fujita, Masato Saitoh, Yukito Hirose, Noriko Urushibara, and Nobumichi Kobayashi. 2021. "Antimicrobial Resistance and Molecular Epidemiological Characteristics of Methicillin-Resistant and Susceptible Staphylococcal Isolates from Oral Cavity of Dental Patients and Staff in Northern Japan" Antibiotics 10, no. 11: 1316. https://doi.org/10.3390/antibiotics10111316

APA Style

Hirose, M., Aung, M. S., Fukuda, A., Yahata, S., Fujita, Y., Saitoh, M., Hirose, Y., Urushibara, N., & Kobayashi, N. (2021). Antimicrobial Resistance and Molecular Epidemiological Characteristics of Methicillin-Resistant and Susceptible Staphylococcal Isolates from Oral Cavity of Dental Patients and Staff in Northern Japan. Antibiotics, 10(11), 1316. https://doi.org/10.3390/antibiotics10111316

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop